de la Fuente, Luis M <br/><br/>
Transendocardial autologous bone marrow in myocardial infarction induced heart failure, two-year follow-up in an open-label phase I safety study (the TABMMI study).  [electronic resource] 

 -  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology  Nov 2011 
 - 805-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1969-6213 
<br/><br/><label>Standard No.: </label>10.4244/EIJV7I7A127  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Argentina<br/>Bone Marrow Transplantation--adverse effects<br/>Catheters<br/>Echocardiography<br/>Electrocardiography, Ambulatory<br/>Equipment Design<br/>Exercise Test<br/>Exercise Tolerance<br/>Female<br/>Fluoroscopy<br/>Heart Failure--diagnosis<br/>Humans<br/>Injections<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--complications<br/>Needles<br/>Radiography, Interventional<br/>Recovery of Function<br/>Stroke Volume<br/>Time Factors<br/>Transplantation, Autologous<br/>Treatment Outcome<br/>Ventricular Function, Left